
Sachem Head Boosts Warner Bros. Discovery Stake Amid Netflix Deal and Paramount Bid
Feb 14, 2026 01:17 am UTC| Business
Activist investor Sachem Head Capital Management significantly increased its investment in Warner Bros. Discovery during the fourth quarter, drawing fresh attention to the media and entertainment companys high-profile...

Feb 14, 2026 01:13 am UTC| Business
Bank of America has approved a total compensation package of $41 million for CEO Brian Moynihan for 2025, marking a 17.1% increase from the previous year. The pay raise reflects the banks strong financial performance and...

Grok AI Market Share Surges as xAI Faces Scrutiny Over Image Generation Controversy
Feb 14, 2026 01:09 am UTC| Business Technology
Elon Musks AI chatbot Grok is rapidly gaining traction in the U.S., even as it faces mounting global criticism over the generation of non-consensual and sexualized AI images. According to data from app intelligence firm...

Lockheed Martin Secures $101M in U.S. Defense Contracts for AEGIS, F-35, and Missile Systems
Feb 14, 2026 01:07 am UTC| Business Technology
Lockheed Martin has been awarded three U.S. Department of Defense contracts worth approximately $101 million, reinforcing its role as a leading defense contractor in advanced military systems, fighter jet support, and...

Feb 14, 2026 01:05 am UTC| Business
Paramount Skydance has appointed Rene Augustine, a former Trump administration attorney, as senior vice president of global public policy, according to a company memo reported by Reuters. The strategic hire comes as...

Senators Urge CFIUS Review of UAE Investment in Trump-Linked Crypto Firm World Liberty Financial
Feb 14, 2026 01:04 am UTC| Business Digital Currency Politics
Two Democratic members of the U.S. Senate Banking Committee are pressing the Treasury Department to review a reported $500 million investment by a senior United Arab Emirates official into World Liberty Financial, a...

Novartis’ Vanrafia Shows Strong Phase 3 Results in IgA Nephropathy, Paving Way for Full Approval
Feb 13, 2026 08:30 am UTC| Business Health
Novartis announced that its investigational drug Vanrafia has successfully demonstrated the ability to slow kidney function decline in adults living with IgA nephropathy (IgAN), a chronic and progressive autoimmune kidney...